Viewing Study NCT05173103

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:12 PM
Ignite Modification Date: 2026-02-23 @ 4:10 AM
Study NCT ID: NCT05173103
Status: COMPLETED
Last Update Posted: 2025-07-25
First Post: 2021-11-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Retrospective Study of 2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2- Advanced Breast Cancer
Sponsor: University of Milano Bicocca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Breast Cancer View
None Hormone Receptor Positive Breast Carcinoma View
None HER2-negative Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None advanced breast cancer View
None hormonal therapy View
None CDK 4/6 inhibitors View